While there is ongoing research to develop better tools like biochemical markers to differentiate fibrosis stage in MASH patients, the only standard currently used in MASH clinical studies involves ...

Biomarker staging of liver fibrosis in hepatitis C was cost effective, but so was initiating treatment without testing.

HPG-1860 is under clinical development by Hepagene Therapeutics Shanghai and currently in Phase I for Inflammatory Bowel Disease.

If Altimmune can't find a partner or be acquired, then a hefty fund raise awaits investors, which could hit the stock. Click ...

Objectives To evaluate GPT-4’s performance in interpreting osteoarthritis (OA) treatment guidelines from the USA and China, ...

Bacterial breaches in immune defences and ineffective clearance exacerbate this risk, placing antimicrobial therapy at the ...

Lucknow: The microbiology department of King George's Medical University (KGMU) will investigate the effectiveness of drugs in treating viral hepatiti.

Trans- versus cisgender adults have an increased prevalence of cirrhosis but similar five-year survival, according t ...

The following is a summary of “Evaluating the GALAD Score for Detection of Hepatocellular Carcinoma in Patients With ...

A Cleveland Clinic liver specialist discusses life expectancy with fatty liver disease and provides tips to take charge of your health.

NewsVoir Bangalore Karnataka [India] December 24 SOUKYA India first NABH-accredited AYUSH hospital and the visionary creation ...